0
     

Report Added
Report already added
Global eClinical Solutions Market 2022-2028

Global eClinical Solutions Market 2022-2028

eClinical solutions enable users to integrate, manage, standardize, and analyze their clinical and operational data through advanced visualization and analytical capabilities. According to Gen Consulting Company, the global eclinical solutions market is projected to reach USD 11,659 million, recording a CAGR of approximately 13.2 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global eclinical solutions market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the eclinical solutions industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, phase, end user, and region. The global market for eclinical solutions can be segmented by product: clinical trial operations management, electronic sourcing & clinical data management systems (CDMS), remote patient monitoring (RPM). Globally, the electronic sourcing & clinical data management systems (CDMS) segment made up the largest share of the eclinical solutions market. Eclinical solutions market is further segmented by phase: phase I, phase II, phase III, phase IV. Based on end user, the eclinical solutions market is segmented into: hospitals, contract research organization (CROs), academia and research institutions, pharmaceutical & biotechnology companies, others. On the basis of region, the eclinical solutions market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By product:
- clinical trial operations management
- electronic sourcing & clinical data management systems (CDMS)
- remote patient monitoring (RPM)

By phase:
- phase I
- phase II
- phase III
- phase IV

By end user:
- hospitals
- contract research organization (CROs)
- academia and research institutions
- pharmaceutical & biotechnology companies
- others

By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)

The report also provides a detailed analysis of several leading eclinical solutions market vendors that include ArisGlobal LLC, Clario (combination of Bioclinica and ERT), DATATRAK International, Inc., ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Medidata Solutions Inc., Oracle Corporation, PAREXEL International Corporation, Veeva Systems Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global eclinical solutions market.
- To classify and forecast the global eclinical solutions market based on product, phase, end user, region.
- To identify drivers and challenges for the global eclinical solutions market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global eclinical solutions market.
- To identify and analyze the profile of leading players operating in the global eclinical solutions market.

Why Choose This Report
- Gain a reliable outlook of the global eclinical solutions market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS

FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Clinical trial operations management
· Electronic sourcing & clinical data management systems (CDMS)
· Remote patient monitoring (RPM)
PART 6. MARKET BREAKDOWN BY PHASE
· Phase I
· Phase II
· Phase III
· Phase IV
PART 7. MARKET BREAKDOWN BY END USER
· Hospitals
· Contract research organization (CROs)
· Academia and research institutions
· Pharmaceutical & biotechnology companies
· Others
PART 8. MARKET BREAKDOWN BY REGION
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
PART 9. KEY COMPANIES
· ArisGlobal LLC
· Clario (combination of Bioclinica and ERT)
· DATATRAK International, Inc.
· ICON plc
· IQVIA Holdings Inc.
· Laboratory Corporation of America Holdings (Labcorp)
· Medidata Solutions Inc.
· Oracle Corporation
· PAREXEL International Corporation
· Veeva Systems Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Report Title: Global eClinical Solutions Market 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline